Karyopharm Therapeutics Inc.

KPTI · Nasdaq · SIC 2834: Pharmaceutical Preparations
260
SEC Filings

Business Summary

6 Item 1A. Risk Factors 54 Item 1B. Unresolved Staff Comments 105 Item 1C. Cybersecurity 105 Item 2. Properties 107 Item 3. Legal Proceedings 107 Item 4. Mine Safety Disclosures 107 PART II 108 Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 108 Item 6. [Reserved] 108 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 109 Item 7A. Quantitative and Qualitative Disclosures about Market Ris...

Next Earnings

Q2 FY2026 — expected 2026-09-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionKPTIdiscussed_in_filing Cybersecurity
topic_mentionKPTIdiscussed_in_filing Cybersecurity
topic_mentionKPTIdiscussed_in_filing Cybersecurity
topic_mentionKPTIdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-132025-12-310001193125-26-049397EDGAR132K words
2025-02-192024-12-310000950170-25-022765EDGAR—
2024-02-292023-12-310000950170-24-022650EDGAR—
2023-02-172022-12-310000950170-23-003129EDGAR—
2022-03-012021-12-310000950170-22-002548EDGAR—
2021-02-242020-12-310001193125-21-054811EDGAR—
2020-02-262019-12-310001193125-20-049115EDGAR—
2019-02-282018-12-310001193125-19-057610EDGAR—
2018-03-152017-12-310001193125-18-084024EDGAR—
2017-03-162016-12-310001193125-17-084396EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-032025-09-300001193125-25-261667EDGAR73K words
2025-08-112025-06-300000950170-25-106238EDGAR—
2025-05-122025-03-310000950170-25-069231EDGAR—
2024-11-052024-09-300000950170-24-121076EDGAR—
2024-08-062024-06-300000950170-24-091210EDGAR—
2024-05-082024-03-310000950170-24-055672EDGAR—
2023-11-022023-09-300000950170-23-057754EDGAR—
2023-08-022023-06-300000950170-23-036780EDGAR—
2023-05-042023-03-310000950170-23-017483EDGAR—
2022-11-032022-09-300000950170-22-021917EDGAR—
2022-08-042022-06-300000950170-22-014788EDGAR—
2022-05-052022-03-310000950170-22-007564EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001503802-26-000011EDGAR1K words
2026-03-240001193125-26-120770EDGAR—
2026-03-030001503802-26-000006EDGAR—
2026-02-190001193125-26-059349EDGAR—
2026-02-120001193125-26-047670EDGAR—
2026-01-120001193125-26-009738EDGAR—
2025-11-030001193125-25-261663EDGAR—
2025-10-140001193125-25-239015EDGAR—
2025-10-080001193125-25-233983EDGAR—
2025-09-110001503802-25-000006EDGAR—

260 total filings indexed. 228 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001503802
TickerKPTI
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 37dd8d173984d03f3ed2be76eb0d36e13f09150596294ba18e617d0ecd9cdd9e
parent: fd23cdf78d4a18bd7f57ffcc17ce8aa6b8efc11e4a97b5e90001309d02d83c5d
content hash: 4c5296ad2f75e6383e60b559f413b92f3471b6f7afc2fdc126cacdbbd24180d5
signed: 2026-04-13T04:45:55.511Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf